Circumventing Cancer Resistance

Bishoy Faltas investigates how chemotherapy, extrachromosomal DNA, and a gene-editing protein create the perfect storm for bladder cancer therapeutic resistance.

| 1 min read
Watercolor illustration of DNA helix overlaid on colorful background with different medications.
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Traditional and new cancer therapies often become stymied due to tumor resistance, but why resistance arises and how to avoid it remain important questions in the cancer research field. To uncover the ways tumors form, adapt, and ultimately resist treatment, scientists investigate how genetic mutations arise and drive cancer cell evolution.

In this episode, Deanna MacNeil from The Scientist spoke with Bishoy Faltas, an associate professor of medicine, and cell and developmental biology, and chief research officer of the Englander Institute for Precision Medicine at Weill Cornell, to explore bladder cancer evolution and treatment resistance.

More on this topic

Skipping Toward Resistance: The Gradual Adaptation of Cancer Cells

Understanding the Effects of Extrachromosomal DNA on Cancer

The Scientist Speaks is a podcast produced by The Scientist’s Creative Services Team. Our podcast is by scientists and for scientists. We bring you the stories behind news-worthy molecular biology research.


Speaker:

Bishoy M. Faltas, MD

Bishoy M. Faltas, MD
Chief Research Officer
Englander Institute for Precision Medicine
Associate Professor of Medicine
Cell and Developmental Biology
Weill Cornell Medicine




Click here to download the episode transcript


You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies